{
  "docId": "019de075-4071-7657-953a-43c246cbe714",
  "docSlug": "684835678957e07d55af9fc01c6da54e",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 44 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 44,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "key_messages",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a matrix structure to map delivery technologies to disease areas, highlighting the role of acquisitions like Pfizer and LogicBio.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de075-4071-7657-953a-43c246cbe714/27",
  "deckHref": "/decks/019de075-4071-7657-953a-43c246cbe714",
  "deckJsonHref": "/decks/019de075-4071-7657-953a-43c246cbe714.json",
  "deckAnchorHref": "/decks/019de075-4071-7657-953a-43c246cbe714#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.14,
        "y": 0.22
      },
      "kind": "diagram",
      "text": "Matrix of therapeutic areas vs delivery platforms",
      "attrs": null,
      "subkind": "nxn-matrix",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02578710-999e-4b6b-b6fb-1c37530e70b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.2,
        "x": 0.77,
        "y": 0.22
      },
      "kind": "list",
      "text": "Furthering our genomic capabilities: accelerating portfolio, combining technologies, partnering for delivery",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "993298ec-5d4c-46d0-b4db-f136d1dd2797",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.83,
        "x": 0.14,
        "y": 0.79
      },
      "kind": "paragraph",
      "text": "Acquisitions and collaborations complement existing AstraZeneca technologies and increases genomic medicine portfolio >4x",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "949d9fa4-1c08-44a0-9185-217d5cb7922e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.02,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "sAAV™ = proprietary adeno-associated virus capsid engineering platform; CRISPR = clustered regularly interspaced short palindromic repeats; C3 = complement protein 3; siRNA = short interfering RNA; LNP = lipid nanoparticle; AAV = adeno-associated virus; CNS = central nervous system; TfR1 = transferrin receptor protein 1. Note: Acquisition of Pfizer preclinical gene therapy programmes subject to customary regulatory clearances and other closing conditions.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d351bb6a-35e3-4207-9852-be755ba3adba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "Rare Disease – R&D highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9172aa2-d774-4cef-9c3c-bcc89586667d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Innovative delivery platforms expanding genomic research",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "548ca332-74a3-4218-9f82-2093b2b83fea",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "NxN matrix",
      "slug": "matrix-nxn",
      "agent": null,
      "layer": "slide",
      "matchId": "3a0a9d4a-27fd-4645-98c3-0a970500ef6c",
      "evidence": "The slide contains a matrix of therapeutic areas vs delivery platforms.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "matrix-nxn",
      "slug": null,
      "matchId": "a126d5f4-4749-4409-acf5-b61e1e74d5bf",
      "evidence": "The slide organizes delivery platforms against therapeutic areas in a grid format.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}